Product
Adempas
Aliases
Adempas Filmtabletten
3 clinical trials
5 indications
Indication
Pulmonary Arterial HypertensionIndication
HypertensionIndication
PulmonaryIndication
Chronic Thromboembolic DiseaseIndication
Post PEA SurgeryClinical trial
Single Dose Oral Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and 'Adempas' (Riociguat) 2.5 mg Filmtabletten (Film Coated Tablets) in Healthy Adult Male Subjects Under Fasting ConditionsStatus: Completed, Estimated PCD: 2023-03-17
Clinical trial
An Open-label, Multi-national, Multi-center, Single-arm, Uncontrolled, Long-term Extension Study of Orally Administered Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH) Who Received Riociguat in a Bayer Clinical TrialStatus: Recruiting, Estimated PCD: 2025-12-28
Clinical trial
Treatment of Exercise-Induced Pulmonary Vascular Dysfunction in Symptomatic Patients After Pulmonary ThromboendarterectomyStatus: Recruiting, Estimated PCD: 2024-12-01